Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > To me

<< Previous

Bullboard Posts

Next >>

Comment by AcynicalJedion Jun 21, 2018 10:08am

70 Views

Post# 28204904

RE:To me

BackInAction wrote:
this wont go above 18.5 Looks like buying has dried up. Few buying at .17 Unless the bids come ask to the ask this may just stay where it sits now.

didnt you say the same thing yesterday then it shot up another 4c?

the day is 30 minutes old relax.

<< Previous

Bullboard Posts

Next >>

Canadian government to fund Electric Royalties portfolio property